Slingshot Insights | Evmn Overview

EVMN Overview

Upcoming Projects (EVMN)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (EVMN)

Evaluating Evommune's EVO756 for Treating Chronic Inducible Urticaria
Tickers: EVMN, NVS, SNY, RHHBY, REGN
Executed On: May 12, 2026 at 10:00 AM EDT
Discussing Evommune's Phase 2 Results of EVO301, a Long-Acting interleukin-18 (IL-18) for Patients with Atopic Dermatitis
Tickers: EVMN, SNY, ABBV, PFE, INCY, LLY, ARQT
Executed On: May 11, 2026 at 09:00 AM EDT

Upcoming & Overdue Catalysts (EVMN)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (EVMN)

Don’t see a strategic initiative related to the company you care about? Create your own!